Financhill
Sell
46

ALC.TO Quote, Financials, Valuation and Earnings

Last price:
$19.50
Seasonality move :
4.91%
Day range:
$18.75 - $19.19
52-week range:
$14.07 - $19.19
Dividend yield:
4.18%
P/E ratio:
7.73x
P/S ratio:
1.03x
P/B ratio:
0.84x
Volume:
10.6K
Avg. volume:
7.4K
1-year change:
29.22%
Market cap:
$776.9M
Revenue:
$703.4M
EPS (TTM):
$2.48

Earnings Data

Next earnings date for ALC.TO
Feb 26
2026
Most recent earnings per share
$0.97
Beat by $0.97
(Nov 4/2025)
Consensus Estimate
--
(Nov 4/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

ALC.TO Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
11/04/2025 Q3 -- $228M $0.97 -- --
06/30/2025 Q2 $208.1M $211.7M $0.81 $0.75 $0.06
05/02/2025 Q1 $119.4M $107.2M -$0.57 -$0.64 $0.07
12/31/2024 Q4 $211.6M $208.6M $1.27 $0.78 $0.49
09/30/2024 Q3 $224.1M $204.6M $0.98 $0.95 $0.03
06/30/2024 Q2 $215.8M $181M $0.44 $0.81 -$0.37
03/31/2024 Q1 $119M $109.2M -$0.44 -$0.64 $0.20
12/31/2023 Q4 $186.6M $201.3M $0.80 $0.57 $0.23
09/30/2023 Q3 $199M $205.9M $0.85 $0.92 -$0.07
06/30/2023 Q2 $206M $202.4M $0.77 $0.76 $0.01
03/31/2023 Q1 -- $111.6M -$0.51 -- --
12/31/2022 Q4 -- $210M $1.28 -- --
09/30/2022 Q3 -- $199.3M $0.99 -- --
06/30/2022 Q2 -- $183.5M $1.10 -- --
03/31/2022 Q1 -- $85.1M -$0.52 -- --
12/31/2021 Q4 -- $178.9M $0.77 -- --
09/30/2021 Q3 -- $174.7M $0.93 -- --
06/30/2021 Q2 -- $167.7M $0.75 -- --
03/31/2021 Q1 -- $77.6M -$0.59 -- --
12/31/2020 Q4 -- $154.3M $0.78 -- --
09/30/2020 Q3 -- $155M $0.53 -- --
06/30/2020 Q2 -- $151.3M $0.42 -- --
03/31/2020 Q1 -- $85.1M -$0.62 -- --
12/31/2019 Q4 -- $169M $0.10 -- --
09/30/2019 Q3 -- $167.9M $0.52 -- --
06/30/2019 Q2 -- $159.2M $0.55 -- --
03/31/2019 Q1 -- $71.9M -$0.59 -- --
12/31/2018 Q4 -- $149.5M $0.64 -- --
09/30/2018 Q3 -- $158.7M $0.49 -- --
06/30/2018 Q2 -- $139.4M $0.36 -- --
03/31/2018 Q1 -- $60.5M -$0.24 -- --
12/31/2017 Q4 -- $139.5M $0.40 -- --
09/30/2017 Q3 -- $137.2M $0.80 -- --
06/30/2017 Q2 -- $124.1M $0.68 -- --
03/31/2017 Q1 -- $52.1M -$0.49 -- --
12/31/2016 Q4 -- $130.6M -$0.30 -- --
09/30/2016 Q3 -- $118.2M $0.91 -- --
06/30/2016 Q2 -- $99M $0.33 -- --
03/31/2016 Q1 -- $40.5M -$0.17 -- --
12/31/2015 Q4 -- $95.2M $0.27 -- --

Algoma Central Corp. Earnings Questions

  • How Much did Algoma Central Corp. Generate in Revenue Last Quarter?

    Algoma Central Corp. reported $228M worth of top line sales in its most recent quarter.

  • Did Algoma Central Corp. Beat Earnings Last Quarter?

    Algoma Central Corp. announced earnings per share of $0.97 which represents a beat of analyst forecast a -- per share.

  • Is Algoma Central Corp. Profitable?

    Algoma Central Corp. reported $59.8M that represents $1.48 per share over the last quarter.

  • What is the Analyst Consensus for Algoma Central Corp. EPS Next Year?

    Algoma Central Corp.'s earnings are forecast to decrease from $2.29 per share to $1.81 per share next year representing a decrease of -17.8%.

  • When is Algoma Central Corp.'s Earnings Date?

    Algoma Central Corp.'s next earnings date is February 26, 2026.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Did Netflix Buy Warner Bros?
Why Did Netflix Buy Warner Bros?

Following a bidding war, Netflix (NASDAQ:NFLX) has announced its intention…

Why Did SoFi Stock Drop?
Why Did SoFi Stock Drop?

Fintech platform SoFi (NASDAQ:SOFI) has stumbled in recent days, selling…

Will Robinhood Win AI Investing?
Will Robinhood Win AI Investing?

Recently, online brokerage Robinhood (NASDAQ:HOOD) has been focused on introducing…

Stock Ideas

Buy
54
Is NVDA Stock a Buy?

Market Cap: $4.5T
P/E Ratio: 63x

Buy
56
Is AAPL Stock a Buy?

Market Cap: $4.1T
P/E Ratio: 37x

Buy
59
Is GOOG Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 39x

Alerts

Buy
67
GPCR alert for Dec 9

Structure Therapeutics, Inc. [GPCR] is down 4.73% over the past day.

Buy
62
SMX alert for Dec 9

SMX (Security Matters) Plc [SMX] is up 7.57% over the past day.

Buy
90
KYMR alert for Dec 9

Kymera Therapeutics, Inc. [KYMR] is down 7.87% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock